Second primary cancers and hormonal therapies for prostate cancer: A nested case–control study
SPC cases were mainly observed among recently exposed patients, which could be linked to a detection bias. The insufficient number of patients exposed over many years means that no definitive conclusions can be drawn.
Authors
- Lucie‐Marie Scailteux (ORCID: https://orcid.org/0000-0001-7047-9107)
- Alexandre Pariente (ORCID: https://orcid.org/0000-0002-7873-5483)
- Julien Bezin (ORCID: https://orcid.org/0000-0002-2568-1928)
- Frédéric Balusson
- Julien Edeline (ORCID: https://orcid.org/0000-0002-8289-7741)
- Emmanuel Oger (ORCID: https://orcid.org/0000-0001-9837-2977)
- Marion Gundelwein
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- École des Hautes Études en Santé Publique (FR)
- Oncogenesis Stress Signaling (FR)
- Bordeaux Population Health (FR)
- Institut de Recherche en Santé, Environnement et Travail (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Université de Rennes (FR)
Publication Details
- Journal
- Fundamental and Clinical Pharmacology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/fcp.70004
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Agence Nationale de Sécurité du Médicament et des Produits de Santé